Glucose News and Research

RSS

Study reveals safety, efficacy of brexpiprazole for schizophrenia patients with severe psychotic symptoms

Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S announced study results on the safety and efficacy of brexpiprazole in the treatment of patients with schizophrenia experiencing severe psychotic symptoms during an acute episode. The data will be presented at the upcoming Psych Congress, held in Orlando from October 25-28, 2018.

26 Oct 2018

High-impact clinical trial results could affect kidney-related medical care

The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented at ASN Kidney Week 2018 October 23-October 28 at the San Diego Convention Center.

26 Oct 2018

Treating gum disease could help people with Type 2 diabetes manage their blood glucose levels

A study funded by Diabetes UK has found that treating periodontitis (gum disease) could help people with Type 2 diabetes manage their blood glucose levels, and may reduce their risk of diabetes-related complications.

25 Oct 2018

New $3.3 million grant will fund human cell atlas of type 1 diabetes

The mechanism leading to development of type 1 diabetes remains a mystery, hampering the ability to find new ways to prevent, treat or even cure this condition.

25 Oct 2018

Stress-induced mental disturbances are directly linked to abnormal glucose metabolism

Chronic stress is a well-known risk factor for the development of psychiatric illnesses including depression disorders. The brain requires a great deal of glucose, and stress is known to alter glucose metabolism.

24 Oct 2018

Most US adults do not engage in muscle-strengthening exercise, study shows

According to a new study in the American Journal of Preventive Medicine, almost 75 percent of US adults do not comply with public health guidelines recommending two or more muscle-strengthening exercise sessions a week, with nearly 60 percent of the population doing no MSE at all.

24 Oct 2018

Study examines factors associated with fasting hyperglucagonemia in type 2 diabetes

A new study examined the relationship between fasting hyperglucagonemia -- which can negatively affect glucose metabolism in patients with type 2 diabetes -- and several biochemical and glycemic factors in subjects with T2D or in a nondiabetic control group.

24 Oct 2018

Researchers uncover new lead for mechanism of action of frontline Type 2 diabetes drug

Canadian and British researchers have discovered how the frontline Type 2 diabetes drug metformin may work to help cells better take up and use glucose.

24 Oct 2018

Study uncovers new mechanism of action in a first-line drug for diabetes

For decades, metformin has been the first-line drug in the treatment of type 2 diabetes, lowering blood glucose levels by inhibiting glucose production in the liver. Metformin also improves glucose uptake and use by muscle tissue.

23 Oct 2018

Paternal exercise has significant impact on child's lifelong metabolic health

Recent studies have linked development of type 2 diabetes and impaired metabolic health individuals to their parents' poor diet, and there is increasing evidence that fathers play an important role in obesity and metabolic programming of their offspring.

22 Oct 2018

Study: Targeting specific genomic mutation in breast cancer improves survival

Targeting a common mutation in patients with hormone receptor positive (HR+) HER2 negative (HER2-) advanced breast cancer with the alpha-specific phosphatidylinositol-3-kinase (PI3K) inhibitor alpelisib significantly improves progression-free survival, according to late-breaking results reported at ESMO 2018.

22 Oct 2018

Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC

Takeda Pharmaceutical Company Limited today announced that intracranial efficacy data from the Phase 3 ALTA-1L (ALK in Lung Cancer Trial of BrigAtinib in 1st Line) trial showed improved intracranial progression-free survival (PFS) and intracranial objective response rate (ORR) with ALUNBRIG (brigatinib) compared to crizotinib among anaplastic lymphoma kinase-positive (ALK+) non-small cell lung cancer (NSCLC) patients.

22 Oct 2018

People with more copies of AMY1 gene digest starchy carbohydrates faster

Found in saliva, the protein enzyme encoded by the AMY1 gene begins the digestive process by breaking down starch when you chew your food.

19 Oct 2018

New pragmatic study launched to understand the effectiveness of new type 2 diabetes drug

HealthCore, Inc., the outcomes research subsidiary of Anthem, Inc. and Novo Nordisk Inc., which manufacturers the once weekly GLP-1 receptor agonist Ozempic (semaglutide), are working together to launch the first of its kind pragmatic study to understand the benefits of semaglutide as compared with all other available diabetes drugs in a real-world pragmatic clinical trial for Type 2 diabetes - one of the nation's fastest growing chronic diseases.

17 Oct 2018

Study finds undiagnosed prediabetes in many infertile men

In a study of 744 infertile men, prediabetes was found in 114 (15.4 percent) of participants. Certain factors were linked with prediabetes in the BJU International study, and they might be useful markers for identifying men who could benefit from early preventive interventions to safeguard against the development of diabetes.

17 Oct 2018

Intensive care patients’ muscles less able to use fats for energy

The muscles of people in intensive care are less able to use fats for energy, contributing to an extensive loss of muscle mass, finds a new study co-led by King's College London, Guy's and St Thomas' NHS Foundation Trust and University College London.

16 Oct 2018

Nutritional quality of breakfast linked to cardiovascular and metabolic risk factors in children

Researchers at the Institute for Innovation and Sustainable Development in the Food Chain of the Public University of Navarre have published a piece of research in which they show that the nutritional quality of breakfast is associated with significant cardiovascular and metabolic risk factors in overweight children (even in those who are fit and who do exercise every day).

16 Oct 2018

Increasing vigorous exercise reduces risk factors of type 2 diabetes, cardiovascular disease in children

Physical exercise can reduce the risk factors of type 2 diabetes and cardiovascular disease even in children, a new study from the University of Eastern Finland shows.

15 Oct 2018

Extension trial assesses benefit of switching from flash monitoring to RT-CGM for hypoglycemia

In follow-up to the I HART CGM study, which showed the benefit of real-time continuous glucose monitoring compared to flash monitoring for time spent in hypoglycemia among adults with type 1 diabetes at high hypoglycemia risk, researchers conducted an extension trial that assessed the effects of continuing RT-CGM or switching from flash to RT-CGM of the subsequent 8 weeks.

15 Oct 2018

Studies demonstrate effect of Ketogenic Diet on cognitive health in animals

We've all experienced a "gut feeling" -- when we know deep down inside that something is true. That phenomenon and others (like "butterflies in the stomach") aptly describe what scientists have now demonstrated: that the gut and the brain are more closely connected than we once thought, and in fact the health of one can affect the other.

12 Oct 2018

Glucose News and Research

Study reveals safety, efficacy of brexpiprazole for schizophrenia patients with severe psychotic symptoms

High-impact clinical trial results could affect kidney-related medical care

Treating gum disease could help people with Type 2 diabetes manage their blood glucose levels

New $3.3 million grant will fund human cell atlas of type 1 diabetes

Stress-induced mental disturbances are directly linked to abnormal glucose metabolism

Most US adults do not engage in muscle-strengthening exercise, study shows

Study examines factors associated with fasting hyperglucagonemia in type 2 diabetes

Researchers uncover new lead for mechanism of action of frontline Type 2 diabetes drug

Study uncovers new mechanism of action in a first-line drug for diabetes

Paternal exercise has significant impact on child's lifelong metabolic health

Study: Targeting specific genomic mutation in breast cancer improves survival

Takeda announces positive Phase 3 ALTA-1L data in first-line therapy for advanced ALK+ NSCLC

People with more copies of AMY1 gene digest starchy carbohydrates faster

New pragmatic study launched to understand the effectiveness of new type 2 diabetes drug

Study finds undiagnosed prediabetes in many infertile men

Intensive care patients’ muscles less able to use fats for energy

Nutritional quality of breakfast linked to cardiovascular and metabolic risk factors in children

Increasing vigorous exercise reduces risk factors of type 2 diabetes, cardiovascular disease in children

Extension trial assesses benefit of switching from flash monitoring to RT-CGM for hypoglycemia

Studies demonstrate effect of Ketogenic Diet on cognitive health in animals

Industry Focus eBook - Cell biology (5th edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News